164 related articles for article (PubMed ID: 32428610)
1. Response to topical corticosteroid monotherapy in mycosis fungoides.
Kartan S; Shalabi D; O'Donnell M; Alpdogan SO; Sahu J; Shi W; Porcu P; Cha J; Nikbakht N
J Am Acad Dermatol; 2021 Mar; 84(3):615-623. PubMed ID: 32428610
[TBL] [Abstract][Full Text] [Related]
2. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
[TBL] [Abstract][Full Text] [Related]
3. Disease characteristics, prognosis, and response to therapy in patients with large-cell transformed mycosis fungoides: A single-center retrospective study.
O'Donnell M; Zaya R; Correia E; Krishnasamy S; Sahu J; Shi W; Cha J; Alpdogan SO; Porcu P; Nikbakht N
J Am Acad Dermatol; 2022 Jun; 86(6):1285-1292. PubMed ID: 34273458
[TBL] [Abstract][Full Text] [Related]
4. Response to Chlormethine/Mechlorethamine gel Maintenance Treatment Regimen in Patients With Mycosis Fungoides: A Single-center Retrospective Study.
Correia E; Krishnasamy S; Suriano JG; Shi W; Alpdogan SO; Sahu J; Porcu P; Nikbakht N
Clin Lymphoma Myeloma Leuk; 2022 Aug; 22(8):581-588. PubMed ID: 35393251
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of O6-Benzylguanine-Potentiated Topical Carmustine for Mycosis Fungoides: A Phase 1-2 Clinical Trial.
Tacastacas JD; Chan DV; Carlson S; Gerson SL; Dowlati A; Fu P; Lu K; Groft S; Rosenjack J; Honda K; McCormick TS; Cooper KD
JAMA Dermatol; 2017 May; 153(5):413-420. PubMed ID: 28199478
[TBL] [Abstract][Full Text] [Related]
6. Tazarotene 0.1% gel for refractory mycosis fungoides lesions: an open-label pilot study.
Apisarnthanarax N; Talpur R; Ward S; Ni X; Kim HW; Duvic M
J Am Acad Dermatol; 2004 Apr; 50(4):600-7. PubMed ID: 15034511
[TBL] [Abstract][Full Text] [Related]
7. Topical nitrogen mustard in the management of mycosis fungoides: update of the Stanford experience.
Kim YH; Martinez G; Varghese A; Hoppe RT
Arch Dermatol; 2003 Feb; 139(2):165-73. PubMed ID: 12588222
[TBL] [Abstract][Full Text] [Related]
8. Total skin electron beam therapy with or without adjuvant topical nitrogen mustard or nitrogen mustard alone as initial treatment of T2 and T3 mycosis fungoides.
Chinn DM; Chow S; Kim YH; Hoppe RT
Int J Radiat Oncol Biol Phys; 1999 Mar; 43(5):951-8. PubMed ID: 10192339
[TBL] [Abstract][Full Text] [Related]
9. Topical corticosteroids for mycosis fungoides. Experience in 79 patients.
Zackheim HS; Kashani-Sabet M; Amin S
Arch Dermatol; 1998 Aug; 134(8):949-54. PubMed ID: 9722724
[TBL] [Abstract][Full Text] [Related]
10. Durable remission of folliculotropic mycosis fungoides achieved with a combined topical treatment with cytarabine and carmustine.
Heisig M; Maj J; Szepietowski JC; Reich A
Dermatol Ther; 2016; 29(1):15-8. PubMed ID: 26278921
[TBL] [Abstract][Full Text] [Related]
11. Topical chemotherapy in cutaneous T-cell lymphoma: positive results of a randomized, controlled, multicenter trial testing the efficacy and safety of a novel mechlorethamine, 0.02%, gel in mycosis fungoides.
Lessin SR; Duvic M; Guitart J; Pandya AG; Strober BE; Olsen EA; Hull CM; Knobler EH; Rook AH; Kim EJ; Naylor MF; Adelson DM; Kimball AB; Wood GS; Sundram U; Wu H; Kim YH
JAMA Dermatol; 2013 Jan; 149(1):25-32. PubMed ID: 23069814
[TBL] [Abstract][Full Text] [Related]
12. Juvenile mycosis fungoides: cutaneous T-cell lymphoma with frequent follicular involvement.
Hodak E; Amitay-Laish I; Feinmesser M; Davidovici B; David M; Zvulunov A; Pavlotsky F; Yaniv I; Avrahami G; Ben-Amitai D
J Am Acad Dermatol; 2014 Jun; 70(6):993-1001. PubMed ID: 24629999
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Low-Dose, Low-Frequency Oral Psoralen-UV-A Treatment With or Without Maintenance on Early-Stage Mycosis Fungoides: A Randomized Clinical Trial.
Vieyra-Garcia P; Fink-Puches R; Porkert S; Lang R; Pöchlauer S; Ratzinger G; Tanew A; Selhofer S; Paul-Gunther S; Hofer A; Gruber-Wackernagel A; Legat F; Patra V; Quehenberger F; Cerroni L; Clark R; Wolf P
JAMA Dermatol; 2019 May; 155(5):538-547. PubMed ID: 30892603
[TBL] [Abstract][Full Text] [Related]
14. Mycosis fungoides in young patients: clinical characteristics and outcome.
Crowley JJ; Nikko A; Varghese A; Hoppe RT; Kim YH
J Am Acad Dermatol; 1998 May; 38(5 Pt 1):696-701. PubMed ID: 9591813
[TBL] [Abstract][Full Text] [Related]
15. Complete resolution of mycosis fungoides tumors with imiquimod 5% cream: a case series.
Lewis DJ; Byekova YA; Emge DA; Duvic M
J Dermatolog Treat; 2017 Sep; 28(6):567-569. PubMed ID: 28635518
[TBL] [Abstract][Full Text] [Related]
16. Topical clobetasol propionate treatment and cutaneous adverse effects in patients with early-stage mycosis fungoides: an observational study.
Geller S; Myskowski PL
Cutis; 2020 May; 105(5):E27-E32. PubMed ID: 32603400
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of a polymerase chain reaction-detectable dominant T-lymphocyte clone in cutaneous lesions of patients with mycosis fungoides.
Delfau-Larue MH; Dalac S; Lepage E; Petrella T; Wechsler J; Farcet JP; Bagot M
Blood; 1998 Nov; 92(9):3376-80. PubMed ID: 9787176
[TBL] [Abstract][Full Text] [Related]
18. Small bowel obstruction due to mycosis fungoides: an unusual presentation.
Velagapudi P; Turagam M; Uzoaru I; Graham D
Am J Med Sci; 2011 Jun; 341(6):508-9. PubMed ID: 21613936
[TBL] [Abstract][Full Text] [Related]
19. Long-term control of mycosis fungoides of the hands with topical bexarotene.
Lain T; Talpur R; Duvic M
Int J Dermatol; 2003 Mar; 42(3):238-41. PubMed ID: 12653924
[TBL] [Abstract][Full Text] [Related]
20. Treatment of mycosis fungoides with photochemotherapy (PUVA): long-term follow-up.
Herrmann JJ; Roenigk HH; Hurria A; Kuzel TM; Samuelson E; Rademaker AW; Rosen ST
J Am Acad Dermatol; 1995 Aug; 33(2 Pt 1):234-42. PubMed ID: 7622650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
